New study aims to decode bowel troubles in rectal cancer survivors

NCT ID NCT06914245

First seen Jan 17, 2026 · Last updated Jun 22, 2026 · Updated 20 times

Summary

This study follows 150 rectal cancer patients to understand why some have lasting bowel problems after treatment. Participants use a smartphone app to track symptoms and fill out quality-of-life questionnaires. The goal is to identify factors that lead to persistent issues, so doctors can create more personalized care plans.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UZ Leuven

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better, personalized care plans for managing bowel symptoms after rectal cancer treatment.

What could go wrong

This is an observational study, not testing a new treatment. It may not directly improve outcomes, and results depend on patient-reported data.

Conditions

The condition(s) this trial relates to.

Low Anterior Resection Syndrome rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.